Training program for neuro-infectious diseases in Uganda
Minnesota-Makerere-Mbarara Neuro-Infectious Disease Research Training Consortium
This study is helping doctors in Uganda learn more about serious brain infections related to HIV, like cryptococcal meningitis and TB meningitis, so they can improve treatment and care for patients in their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11173825 on NIH RePORTER |
What this research studies
This research focuses on addressing central nervous system infections, particularly those related to HIV, such as cryptococcal meningitis and TB meningitis, which significantly impact health in Sub-Saharan Africa. The program aims to provide intensive training for Ugandan medical professionals in various fields including clinical research, biostatistics, and neurology. Participants will engage in mentored research experiences to enhance their skills, publish their findings, and prepare for advanced research opportunities. The initiative builds on a successful partnership that has already contributed to significant advancements in the field.
Who could benefit from this research
Good fit: Ideal candidates for this research are healthcare professionals in Uganda who have completed their Master's of Medicine and are seeking further training in neuro-infectious diseases.
Not a fit: Patients who are not healthcare professionals or those outside of the Sub-Saharan Africa region may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of neuro-infectious diseases, ultimately reducing mortality and morbidity in affected populations.
How similar studies have performed: Previous research initiatives in this area have shown success, with over 150 publications and several Ugandan researchers securing independent funding.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Boulware, David R — University of Minnesota
- Study coordinator: Boulware, David R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.